Atlanta Consulting Group Advisors »

Amneal Pharmaceuticals shares owned by Atlanta Consulting Group Advisors

Quarter-by-quarter ownership of Amneal Pharmaceuticals (AMRX) shares owned by Atlanta Consulting Group Advisors from 13F filings

Historical chart of Atlanta Consulting Group Advisors investment in Amneal Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Amneal Pharmaceuticals held by Atlanta Consulting Group Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Amneal Pharmaceuticals by Atlanta Consulting Group Advisors

Quarter filed Position value Share count Share price at filing
2024-06-30 $64k 10k 6.35
2024-03-31 $61k 10k 6.06

More positions owned by Atlanta Consulting Group Advisors

Ishares Tr Core S&p500 Etf (IVV)
Ishares Tr Core S&p Scp Etf (IJR)
Invesco Exchange Traded Fd T S&p500 Eql Wgt (RSP)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Ishares Tr Core S&p Mcp Etf (IJH)
Berkshire Hathaway Inc Del Cl A (BRK.A)
Ishares Core Msci Emkt (IEMG)
Ishares Tr Core Msci Eafe (IEFA)
JPMorgan Chase & Co. (JPM)
Microsoft Corporation (MSFT)
Ishares Tr Iboxx Hi Yd Etf (HYG)
Coca-Cola Company (KO)
Vanguard Intl Equity Index F Ftse Smcap Etf (VSS)
Churchill Downs (CHDN)
Berkshire Hathaway Inc Del Cl B New (BRK.B)

View all positions for Atlanta Consulting Group Advisors

Top funds holding Amneal Pharmaceuticals

Vanguard Group
Tpg Gp A
BlackRock
Rubric Capital Management
Citadel Advisors
Fosun International
Dimensional Fund Advisors
Neuberger Berman Group
Geode Capital Management
State Street Corporation
Nantahala Capital Management
Nuveen Asset Management
BlackBarn Capital Partners
Hennessy Advisors
Goldman Sachs Group

View all funds holding Amneal Pharmaceuticals